{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02717858","recordId":"NCT02717858","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02717858-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02717858.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02717858.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-03-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-03-18","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"180ab09fa2086480d688ec33b8b8e3a16d1ee0094e6e7429959c5d40526dd0b6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-04-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-04-04","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"0683e8101b82762ad682d9510719a8fbba59915aa897818c8f2cbb73f91f8794","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-11-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-16","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"5920617e630037ad1adc18df75dddca7921b03462cfaf740b1edb63749e5132c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-12-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-12-08","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"d55dc4996439e04efd081465f316a2b4ac6d395b4bf9f70b6547c7d2f558b74c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-03-03","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"b301fa373d455740b2737e9a034397ee46f4b71ddeb72cf5ee1e8405a3bf3438","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-07-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-07-24","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"94781cd37f5d449100a94411473ebf904bf665e4255a498d69bd31faee566cef","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2018-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-06-26","publishedAt":"2026-08-23","recordId":"NCT02717858","recordSha256":"3612eb457a16b571f8fa86b7425cf2f36aed41490c33bb7a3111be0dedeb0996","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02717858?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"b3441deee0e6f9370783c5cea9c77de94c2e4ddcb6b8568c92f066ca85f4a2a2"}}
